News
1h
AllAfrica on MSNMomentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To ActionNew WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...
2h
The Kenya Times on MSNWHO Awards Uhuru Kenyatta for Championing Pandemic AgreementFormer President Uhuru Kenyatta has received an award from the World Health Organization (WHO). WHO formally recognized the ...
U.N. health officials have estimated that more than 14 million children did not receive a single vaccine last year.
An estimated 14.3 million children globally remain completely unvaccinated, according to a new report, and public health ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.
Menzies School of Health Research has led the largest-ever study of people living with a unique strain of chronic hepatitis B ...
The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
The World Health Organization has formally recognized the pivotal role of a number of heads of state and government in securing the adoption of the WHO Pandemic Agreement by the Seventy-eighth World ...
A World Health Organization (WHO) group focused on food safety held an event recently to mark one year of existence. The WHO ...
A leading expert in the health impacts of plastic pollution and microplastics is calling on the UN to end the use of toxic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results